MOBILE, Ala., Aug. 2 /PRNewswire-FirstCall/ -- Hasco Medical, Inc. (OTC Bulletin Board: HASC), www.mysouthernmed.com,
As America's first orthopedics company, Bell-Horn has been supplying the world with first-class orthopedics since 1842. Under the terms of the agreement, Hasco Medical will distribute the products throughout the country online and at its retail locations. Hal Compton, Jr., Hasco CEO stated, "The distribution agreement with Bell-Horn opens up additional revenue streams we have been unable to tap to this point. Now we have the leading Orthopedics products in the world. We will begin to offer orthopedic braces, supports and compression hosiery directly to our customers. With Bell-Horn, we can now take our offering to hospitals, pharmacies, and healthcare providers around the world. This is really going to move the revenue needle north."
Additionally, Hasco and Bell-Horn will jointly promote sales through point-of-purchase (POP) marketing materials and customizable orthopedic planograms. The POP displays will include displays with fitting and sizing charts to better inform the customer at the time a buying decision is made.
About Hasco Medical, Inc.
Hasco Medical, Inc., is a managed healthcare provider of a broad range of home healthcare services that serve patients in Alabama, Florida, and Mississippi. The Company has two major service lines: home respiratory equipment and durable/ home medical equipment. The Company's objective is to be a leading provider of home health care products and services in the continental United States.
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
SOURCE Hasco Medical, Inc.
Subscribe to our Free Newsletters!
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...
Rosacea is a chronic skin condition marked by facial redness and swelling especially around the ...
Immunotherapy is a type of treatment method that works by using certain components of a person's ...View All